#Antibacterial Drugs#

Eli Lilly Partners with OpenAI to Develop New Antibacterial Drugs

The US pharma giant Eli Lilly teams up with OpenAI to combat drug-resistant pathogens, a global health threat, with new AI-driven approaches.